Prostate cancer screening: what's a fellow to do?
- PMID: 20397489
Prostate cancer screening: what's a fellow to do?
Abstract
Prostate cancer is responsible for more than 27,000 deaths annually and is the most common non-skin cancer of men in North America. Over the years, a variety of screening approaches have been recommended. Despite increased sensitivity of the tests and effective public awareness campaigns, screening for this cancer remains surprisingly controversial. In this article, we review what makes a good screening test. We also review the evidence behind screening for prostate cancer and the current screening recommendations by a variety of reputable organizations.
Similar articles
-
Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians.Can J Urol. 2010 Feb;17 Suppl 1:18-25. Can J Urol. 2010. PMID: 20170597 Review.
-
American Cancer Society guideline for the early detection of prostate cancer: update 2010.CA Cancer J Clin. 2010 Mar-Apr;60(2):70-98. doi: 10.3322/caac.20066. Epub 2010 Mar 3. CA Cancer J Clin. 2010. PMID: 20200110 Review.
-
Screening for prostate cancer in asymptomatic men: clinical, legal, and ethical implications.Oncol Nurs Forum. 1998 Oct;25(9):1561-9. Oncol Nurs Forum. 1998. PMID: 9802052 Review.
-
Guideline update: what's the best approach for screening asymptomatic men for prostate cancer?J Fam Pract. 2009 Dec;58(12):E2. J Fam Pract. 2009. PMID: 19961813
-
Introducing the 2010 American Cancer Society prostate cancer screening guideline.CA Cancer J Clin. 2010 Mar-Apr;60(2):68-9. doi: 10.3322/caac.20067. Epub 2010 Mar 3. CA Cancer J Clin. 2010. PMID: 20200111 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Medical